APO RESEARCH · REPORT
Levonorgestrel
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Product & engineering
Understand the product.
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Selected research
Market Structure
Global Levonorgestrel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Europe is the largest Levonorgestrel market with about 43% market share. Asia-Pacific is follower, accounting for about 29% market share.The key manufacturers are Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma etc. Top 3 companies occupied about 68% market share.
This report provides an overview of the global Levonorgestrel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Levonorgestrel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Levonorgestrel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Levonorgestrel market size, projected growth trends, production technologies, key applications, and end-use industries.
Levonorgestrel Segment by Company
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
Levonorgestrel Segment by Type
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD
Levonorgestrel Segment by Application
Hospital
Drug Store
Online Sale
Levonorgestrel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levonorgestrel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levonorgestrel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levonorgestrel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Levonorgestrel market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Levonorgestrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Levonorgestrel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Levonorgestrel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel Table
- Mixture Products
- Hormone-releasing IUD
Applications
- Hospital
- Drug Store
- Online Sale
Companies covered
- Bayer
- Paladin Labs
- Foundation Consumer Healthcare
- Theramex (Teva)
- Pfizer
- Apotex
- HRA Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Levonorgestrel Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Levonorgestrel Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Levonorgestrel Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Levonorgestrel Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Levonorgestrel Market Dynamics
- 2.1 Levonorgestrel Industry Trends
- 2.2 Levonorgestrel Industry Drivers
- 2.3 Levonorgestrel Industry Opportunities and Challenges
- 2.4 Levonorgestrel Industry Restraints
3 Levonorgestrel Market by Manufacturers
- 3.1 Global Levonorgestrel Revenue by Manufacturers (2021-2026)
- 3.2 Global Levonorgestrel Sales by Manufacturers (2021-2026)
- 3.3 Global Levonorgestrel Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Levonorgestrel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Levonorgestrel Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Levonorgestrel Manufacturers, Product Type & Application
- 3.7 Global Levonorgestrel Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Levonorgestrel Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Levonorgestrel Players Market Share by Revenue in 2025
- 3.8.3 2025 Levonorgestrel Tier 1, Tier 2, and Tier 3
4 Levonorgestrel Market by Type
- 4.1 Levonorgestrel Type Introduction
- 4.1.1 Levonorgestrel Table
- 4.1.2 Mixture Products
- 4.1.3 Hormone-releasing IUD
- 4.2 Global Levonorgestrel Sales by Type
- 4.2.1 Global Levonorgestrel Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Levonorgestrel Sales by Type (2021-2032)
- 4.2.3 Global Levonorgestrel Sales Market Share by Type (2021-2032)
- 4.3 Global Levonorgestrel Revenue by Type
- 4.3.1 Global Levonorgestrel Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Levonorgestrel Revenue by Type (2021-2032)
- 4.3.3 Global Levonorgestrel Revenue Market Share by Type (2021-2032)
5 Levonorgestrel Market by Application
- 5.1 Levonorgestrel Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.1.3 Online Sale
- 5.2 Global Levonorgestrel Sales by Application
- 5.2.1 Global Levonorgestrel Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Levonorgestrel Sales by Application (2021-2032)
- 5.2.3 Global Levonorgestrel Sales Market Share by Application (2021-2032)
- 5.3 Global Levonorgestrel Revenue by Application
- 5.3.1 Global Levonorgestrel Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Levonorgestrel Revenue by Application (2021-2032)
- 5.3.3 Global Levonorgestrel Revenue Market Share by Application (2021-2032)
6 Global Levonorgestrel Sales by Region
- 6.1 Global Levonorgestrel Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Levonorgestrel Sales by Region (2021-2032)
- 6.2.1 Global Levonorgestrel Sales by Region (2021-2026)
- 6.2.2 Global Levonorgestrel Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Levonorgestrel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Levonorgestrel Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Levonorgestrel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Levonorgestrel Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Levonorgestrel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Levonorgestrel Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Levonorgestrel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Levonorgestrel Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Levonorgestrel Revenue by Region
- 7.1 Global Levonorgestrel Revenue by Region
- 7.1.1 Global Levonorgestrel Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Levonorgestrel Revenue by Region (2021-2026)
- 7.1.3 Global Levonorgestrel Revenue by Region (2027-2032)
- 7.1.4 Global Levonorgestrel Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Levonorgestrel Revenue (2021-2032)
- 7.2.2 North America Levonorgestrel Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Levonorgestrel Revenue (2021-2032)
- 7.3.2 Europe Levonorgestrel Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Levonorgestrel Revenue (2021-2032)
- 7.4.2 Asia-Pacific Levonorgestrel Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Levonorgestrel Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Levonorgestrel Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bayer
- 8.1.1 Bayer Company Information
- 8.1.2 Bayer Business Overview
- 8.1.3 Bayer Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bayer Levonorgestrel Product Portfolio
- 8.1.5 Bayer Recent Developments
- 8.2 Paladin Labs
- 8.2.1 Paladin Labs Company Information
- 8.2.2 Paladin Labs Business Overview
- 8.2.3 Paladin Labs Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Paladin Labs Levonorgestrel Product Portfolio
- 8.2.5 Paladin Labs Recent Developments
- 8.3 Foundation Consumer Healthcare
- 8.3.1 Foundation Consumer Healthcare Company Information
- 8.3.2 Foundation Consumer Healthcare Business Overview
- 8.3.3 Foundation Consumer Healthcare Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Foundation Consumer Healthcare Levonorgestrel Product Portfolio
- 8.3.5 Foundation Consumer Healthcare Recent Developments
- 8.4 Theramex (Teva)
- 8.4.1 Theramex (Teva) Company Information
- 8.4.2 Theramex (Teva) Business Overview
- 8.4.3 Theramex (Teva) Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Theramex (Teva) Levonorgestrel Product Portfolio
- 8.4.5 Theramex (Teva) Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Levonorgestrel Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 Apotex
- 8.6.1 Apotex Company Information
- 8.6.2 Apotex Business Overview
- 8.6.3 Apotex Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Apotex Levonorgestrel Product Portfolio
- 8.6.5 Apotex Recent Developments
- 8.7 HRA Pharma
- 8.7.1 HRA Pharma Company Information
- 8.7.2 HRA Pharma Business Overview
- 8.7.3 HRA Pharma Levonorgestrel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 HRA Pharma Levonorgestrel Product Portfolio
- 8.7.5 HRA Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Levonorgestrel Value Chain Analysis
- 9.1.1 Levonorgestrel Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Levonorgestrel Production Mode & Process
- 9.2 Levonorgestrel Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Levonorgestrel Distributors
- 9.2.3 Levonorgestrel Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst